Suraj Kalia
Stock Analyst at Oppenheimer
(3.65)
# 768
Out of 4,868 analysts
79
Total ratings
45.59%
Success rate
8.65%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $124.00 | +20.97% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $31.57 | +42.54% | 7 | Feb 13, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $7.69 | +199.28% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $145.53 | -17.54% | 5 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $29.70 | +7.74% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $81.76 | +13.75% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $132.41 | -1.82% | 1 | Oct 8, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $10 | $5.50 | +81.82% | 1 | Sep 16, 2024 | |
| EW Edwards Lifesciences | Maintains: Outperform | $90 | $73.98 | +21.65% | 5 | Sep 12, 2024 | |
| NYXH Nyxoah | Maintains: Outperform | $15 → $13 | $7.72 | +68.39% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $118.96 | +13.48% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $250.88 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $9.96 | +201.20% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $10 | $0.20 | +4,843.15% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $71.89 | +34.93% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $21.56 | +29.87% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $2.16 | +108.33% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $2.36 | +577.97% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $509.49 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $2.41 | +27,285.89% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $129.70 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $5.05 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $29.80 | +235.57% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $81.01 | - | 5 | Sep 12, 2018 |
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $124.00
Upside: +20.97%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $31.57
Upside: +42.54%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $7.69
Upside: +199.28%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $145.53
Upside: -17.54%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $29.70
Upside: +7.74%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $81.76
Upside: +13.75%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $132.41
Upside: -1.82%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $5.50
Upside: +81.82%
Edwards Lifesciences
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $73.98
Upside: +21.65%
Nyxoah
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $7.72
Upside: +68.39%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $118.96
Upside: +13.48%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $250.88
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $9.96
Upside: +201.20%
Jun 23, 2023
Maintains: Outperform
Price Target: $16 → $10
Current: $0.20
Upside: +4,843.15%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $71.89
Upside: +34.93%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $21.56
Upside: +29.87%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $2.16
Upside: +108.33%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $2.36
Upside: +577.97%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $509.49
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $2.41
Upside: +27,285.89%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $129.70
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $5.05
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $29.80
Upside: +235.57%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $81.01
Upside: -